{"id":2953,"date":"2022-08-25T13:11:24","date_gmt":"2022-08-25T17:11:24","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=2953"},"modified":"2026-04-13T15:28:13","modified_gmt":"2026-04-13T19:28:13","slug":"what-is-aptamers","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/es\/what-is-aptamers\/","title":{"rendered":"What is An Aptamer?"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Finding a diagnostic reagent that is right for a point-of-care application can be tricky due to the long list of obstacles that need to be overcome. The reagent needs to be shelf-stable, give reproducibly sensitive and selective results, be easy to synthesize, and most importantly, be inexpensive. For many diagnostic reagents on the market currently, such as antibodies, all of these criteria are not satisfied, and this is the primary cause of pain to diagnostic kit providers. Aptamers check all the boxes on this list.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h3>What is An Aptamer?<\/h3>\n<p><span style=\"font-weight: 400;\">Aptamers are short single stranded DNA or RNA molecules that can selectively bind to any target that they are designed to bind to. Since aptamers are single-stranded, they can assume a variety of different three-dimensional structures, such as loops and stems. The large variety of shapes possible allows aptamers to have high selectivity and specificity. Aptamers are not made in living organisms; they are synthesized on an instrument. This means that we have complete reproducibility in performance from batch-to-batch of synthesis. Given that the selection of aptamers is done on a lab bench and not inside an animal, the targets for binding can be anything from cells and large biomolecules down to small molecules that would not be sufficiently antigenic for antibodies.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-2934\" src=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Screen-Shot-2022-08-22-at-3.55.36-PM.png\" alt=\"An aptamer binding to a target\" width=\"1252\" height=\"352\" srcset=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Screen-Shot-2022-08-22-at-3.55.36-PM.png 1252w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Screen-Shot-2022-08-22-at-3.55.36-PM-300x84.png 300w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Screen-Shot-2022-08-22-at-3.55.36-PM-1024x288.png 1024w, https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Screen-Shot-2022-08-22-at-3.55.36-PM-768x216.png 768w\" sizes=\"(max-width: 1252px) 100vw, 1252px\" \/><\/p>\n<p>&nbsp;<\/p>\n<h3>Why Aptamers?<\/h3>\n<p><span style=\"font-weight: 400;\">The use of aptamers in the detection or selection of targets has been around for decades. The technology to make aptamer design quicker and more selective is continually getting better. Currently we have the capacity to complete an entire aptamer selection and delivery project in three months. Aptamers can be shipped, stored, and used at various temperatures, which makes then more reliable and robust for diagnostic tests than antibodies. Aptamers have shown to be promising tools not only in the diagnostic world, but also in the therapeutic space where drugs can be attached to them in order to deliver treatments to specific cells.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">At NeoVentures we have revolutionized the selection of aptamers and can optimize the structure to increase the binding affinity to targets. <a href=\"https:\/\/neoaptamers.com\/es\/contact-us\/\">To learn more, get in touch with our team today.<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Finding a diagnostic reagent that is right for a point-of-care application can be tricky due to the long list of obstacles that need to be overcome. The reagent needs to be shelf-stable, give reproducibly sensitive and selective results, be easy to synthesize, and most importantly, be inexpensive. For many diagnostic reagents on the market currently,&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/es\/what-is-aptamers\/\" rel=\"bookmark\">Leer m\u00e1s &raquo;<span class=\"screen-reader-text\">What is An Aptamer?<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":2932,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8,30],"tags":[],"class_list":["post-2953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers","category-introductory"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What is An Aptamer?<\/title>\n<meta name=\"description\" content=\"Learn the basics of aptamers, how they work, and why you should be using aptamers instead of antibodies in commercial applications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/es\/what-is-aptamers\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What is An Aptamer?\" \/>\n<meta property=\"og:description\" content=\"Learn the basics of aptamers, how they work, and why you should be using aptamers instead of antibodies in commercial applications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/es\/what-is-aptamers\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-25T17:11:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T19:28:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/unnamed-17.png\" \/>\n\t<meta property=\"og:image:width\" content=\"512\" \/>\n\t<meta property=\"og:image:height\" content=\"259\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"What is An Aptamer?\",\"datePublished\":\"2022-08-25T17:11:24+00:00\",\"dateModified\":\"2026-04-13T19:28:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/\"},\"wordCount\":355,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/unnamed-17.png\",\"articleSection\":[\"Aptamers\",\"Introductory\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/\",\"name\":\"What is An Aptamer?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/unnamed-17.png\",\"datePublished\":\"2022-08-25T17:11:24+00:00\",\"dateModified\":\"2026-04-13T19:28:13+00:00\",\"description\":\"Learn the basics of aptamers, how they work, and why you should be using aptamers instead of antibodies in commercial applications.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/unnamed-17.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/unnamed-17.png\",\"width\":512,\"height\":259},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/what-is-aptamers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What is An Aptamer?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What is An Aptamer?","description":"Learn the basics of aptamers, how they work, and why you should be using aptamers instead of antibodies in commercial applications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/es\/what-is-aptamers\/","og_locale":"es_ES","og_type":"article","og_title":"What is An Aptamer?","og_description":"Learn the basics of aptamers, how they work, and why you should be using aptamers instead of antibodies in commercial applications.","og_url":"https:\/\/neoaptamers.com\/es\/what-is-aptamers\/","og_site_name":"neoaptamers","article_published_time":"2022-08-25T17:11:24+00:00","article_modified_time":"2026-04-13T19:28:13+00:00","og_image":[{"width":512,"height":259,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/unnamed-17.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gregory Penner","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"What is An Aptamer?","datePublished":"2022-08-25T17:11:24+00:00","dateModified":"2026-04-13T19:28:13+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/"},"wordCount":355,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/unnamed-17.png","articleSection":["Aptamers","Introductory"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/","url":"https:\/\/neoaptamers.com\/what-is-aptamers\/","name":"What is An Aptamer?","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/unnamed-17.png","datePublished":"2022-08-25T17:11:24+00:00","dateModified":"2026-04-13T19:28:13+00:00","description":"Learn the basics of aptamers, how they work, and why you should be using aptamers instead of antibodies in commercial applications.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/what-is-aptamers\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/unnamed-17.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/unnamed-17.png","width":512,"height":259},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/what-is-aptamers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"What is An Aptamer?"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/2953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/comments?post=2953"}],"version-history":[{"count":1,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/2953\/revisions"}],"predecessor-version":[{"id":2954,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/2953\/revisions\/2954"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media\/2932"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media?parent=2953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/categories?post=2953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/tags?post=2953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}